MedTrace Logo

Effect of Inflammation on Pharmacokinetics of Posaconazole

NCT02492802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2019-08-06

Study results available
· View outcomes & findings →

Summary

Posaconazole plasma concentration and inflammatory markers will be determined in all samples available from routine analysis.

Conditions

  • Mycoses

Interventions

DRUG

posaconazole

collection plasma samples for measuring posaconazole drug concentration

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Jan-Willem Alffenaar, PharmD, PhD · UMCG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-13
Primary Completion
2017-06-01
Completion
2017-08-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02492802 on ClinicalTrials.gov